Tissue engineering is a rapidly developing field of medicine where the combination of highly advanced synthetic materials in combination with human cells and biologically active molecules are converted into functional tissues that restore, maintain or improve damaged non-functional tissue. Recently, 3D printable constructs with brain tissue characteristics were developed, suggesting new and exciting approaches to treat damaged neuronal tissue.
Stem cells hold great potential as a therapy for neuronal diseases. Stem cells have the potential to be manipulated into multiple lineages of functional neuronal cell types for the replacement of damaged neural tissue. Human stem cells, whether taken naively from a donor or modified by various advanced molecular, genetic and epi-genetic techniques are a cornerstone of many new therapies. Latest developments in stem cell research demonstrates intriguing therapeutic effect of modified and engineered stem cells on injured neuronal tissue and non-functional neurons in various neurological pathologies.
ARTIFICIAL INTELLIGENCE (AI) and MACHINE LEARNING (ML)
AI and ML are rapidly emerging branches of computer science and mathematics that use advanced software based algorithms and heuristics to provide insights, identify hidden patterns and provide information extracted from large amounts of research data in a way that exceeds human deduction capabilities. AI and ML solutions are already embedded in many real world applications including autonomous cars, business intelligence and expert systems. There is now a growing usage of AI and ML in biotechnology research to improve the accuracy, predictability and speed of drug discovey. AI predictive tools may open up new research lines enabling more competitive R&D strategies. Undiscovered startups are in the forefront in harnessing these technologies so as to identify new treatments for neuronal diseases.
Contact info: 50 Battery Pl, #7T, New York, NY 10280 phone: 212-945-2080, firstname.lastname@example.org